Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Innovative Versatility: Examples of overcoming adversity from Entrepreneurs - 2At least 11 killed in South Africa mass shooting
- 3The Most Vital Crossroads in Olympic History
- 4Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- 5Cyclone Narelle turns Australian skies blood red in ‘apocalyptic’ scenes
- Artemis II astronauts make long-distance call to the space station as they head home from the moon
- Mummified cheetahs found in Saudi caves shed light on lost populations
- Catch the moon dancing with bright star Regulus tonight
- 5 Breakout Stars in Ongoing television Series
- Polls open in tense Uganda election amid widespread delays
- Surveys of Music Collections by Film Stars
- Catholic influencer shares death of 5-year-old son from 'severe' flu
- The Best Computer games for Multiplayer Fun
- Vote In favor of Your Favored Video Conferencing Administration
